A Hydrophilic Nanoparticle mRNA-Based Platform Enabling Targeted Delivery & Inducing Immune Tolerance in Autoimmune Diseases
10:00 am - Thursday 25th March 2027
- Introduction to the NanoGalaxy hydrophilic nanoparticle (HNP) mRNA delivery platform
- HNP-mRNA biodistribution, immune cell engagement, and safety in mice and nonhuman primates
- Application of the HNP-mRNA platform to induce immune tolerance in autoimmune indications
